Skip to content
Screener

Armata Pharmaceuticals ARMP Q4 2025 Annual earnings

Reported March 25, 2026 · Before market open

Revenue$1.1MBeat by $360.0K
EPS-$0.51Miss by $0.32
Revenue estimate$740.0K
EPS estimate-$0.19

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$450.0K
EPS estimate-$0.57

FAQ

When did Armata Pharmaceuticals report Q4 2025 earnings?
Armata Pharmaceuticals (ARMP) reported Q4 2025 earnings on March 25, 2026 before market open.
What were Armata Pharmaceuticals's Q4 2025 revenue and EPS?
Armata Pharmaceuticals reported revenue of $1.1M and eps of $-0.51 for Q4 2025.
Did Armata Pharmaceuticals beat estimates in Q4 2025?
Revenue beat the consensus estimate of $740.0K by $360.0K. EPS missed the consensus estimate of $-0.19 by $0.32.
How did Armata Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 10.9% from $1.2M a year earlier and eps declined 121.7% from $-0.23.
Where can I find Armata Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-034523) and the 10-K periodic report (0001104659-26-034532) directly on SEC EDGAR. The filing index links above go to sec.gov.